Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-25-000126
Filing Date
2025-11-13
Accepted
2025-11-13 07:31:10
Documents
66
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20250930.htm   iXBRL 10-Q 986611
2 EX-31.1 a2025-q310xqex311.htm EX-31.1 10603
3 EX-31.2 a2025-q310xqex312.htm EX-31.2 10689
4 EX-32.1 a2025-q310xqex321.htm EX-32.1 4888
5 EX-32.2 a2025-q310xqex322.htm EX-32.2 4906
11 abus-20250930_g1.jpg GRAPHIC 56927
  Complete submission text file 0001447028-25-000126.txt   5633939

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20250930.xsd EX-101.SCH 40527
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20250930_cal.xml EX-101.CAL 43696
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20250930_def.xml EX-101.DEF 205899
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20250930_lab.xml EX-101.LAB 523561
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20250930_pre.xml EX-101.PRE 367301
69 EXTRACTED XBRL INSTANCE DOCUMENT abus-20250930_htm.xml XML 661847
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 251475415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)